Cargando…
Facile and rapid detection of respiratory syncytial virus using metallic nanoparticles
BACKGROUND: Respiratory syncytial virus (RSV) causes severe respiratory infection in infants, children and elderly. Currently, there is no effective vaccine or RSV specific drug for the treatment. However, an antiviral drug ribavirin and palivizumab is prescribed along with symptomatic treatment. RS...
Autores principales: | Valdez, Jesus, Bawage, Swapnil, Gomez, Idalia, Singh, Shree Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769566/ https://www.ncbi.nlm.nih.gov/pubmed/26921130 http://dx.doi.org/10.1186/s12951-016-0167-z |
Ejemplares similares
-
Recent Advances in Diagnosis, Prevention, and Treatment of Human Respiratory Syncytial Virus
por: Bawage, Swapnil Subhash, et al.
Publicado: (2013) -
Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection
por: Bawage, Swapnil S., et al.
Publicado: (2019) -
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Tiwari, Pooja Munnilal, et al.
Publicado: (2018) -
Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus †
por: Joshi, Sameer, et al.
Publicado: (2018) -
Bioconjugated nanoparticle detection of respiratory syncytial virus infection
por: Tripp, Ralph A, et al.
Publicado: (2007)